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Abstract:  
 
      Folate receptor has achieved great importance for use in targeted drug delivery and in vitro 
and in vivo diagnostic assays
1-2
.  Folate receptor (FR) is over expressed on several cancer cell 
types and activated macrophages, but exists in relatively low abundance on the surface of non-
cancerous tissue and non-inflammatory cells. This unique attribute is the hallmark of folate – 
targeted methodologies allowing the diagnostic agent and/or drug to be ferried to the specific 
disease sites while preventing “off target” effects in normal tissues3-4. Although several folate-
based dyes have been reported, simple and detailed synthetic and purification methods for these 
conjugates have not been reported. Our objective is to develop a new folate-based dye and the 
corresponding HPLC methods for the purification and analysis of this conjugate. Folate-
Dylight
TM
 800 was successfully synthesized by very simple, inexpensive and safe method. The 
whole synthesis method can be performed in small laboratories with minimum resources and 
small quantity of reagents required. The synthesis of Folate-Dylight
TM
 800 conjugate was 
successfully purified by HPLC. The purified Folate-Dylight
TM
 800 conjugate was evaluated by 
microplate reader, UV-Vis and HPLC.  
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Introduction:  
 
Folic Acid: (Figure: 1) 
Folic acid or vitamin B9 is a water soluble vitamin. Folic acid from food and supplements  
is biologically inactive in the body. The reduced form i.e. Tetrahydrofolate (THF), which is the 
active form of Folic acid, plays a key role in the metabolic activity of the body. It is necessary 
for the normal and healthy growth of cells because it acts as a coenzyme for DNA and RNA 
synthesis.
5-6
 Folate is a vital nutrition for pregnant women as it helps in the reproduction of cells 
and growth in the foetus. Deficiency of folic acid may result in improper effects on cell division 
and protein synthesis and therefore causes impairment of growth. In the presence of Folic acid 
and Cyanacobalmine (Vit B12)  conversion of homocysteine to methionine takes place thereby 
reducing the blood levels of homocysteine and thus decreasing the risk of heart related 
problems.
7
 It maintains a healthy nervous system’s by involving in the production of 
neurotransmitters  which regulate mood, sleep and appetite. It also prevents urinary tract 
infections. Neural tube effects can be avoided if the pregnant women include folic acid into their  
daily diet
8-9
. Low levels of folic acid may result in cancers of cervix, colon and lungs. Red blood 
cells are particularly susceptible to folic acid deficiency; hence causing anaemia
10
. Folate also 
plays a crucial role in the metabolism of many amino acids which include histidine, glycine and 
methionine
11
. 
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Folate receptor: 
Folate receptors are present on the cell surface. They are surface glycoprotein with high 
affinity for folic acid and folate, which capture the folate from the extracellular liquid and 
transports to the cell
11-12
. The folate receptors are present on the normal cells, however there is 
greater receptor presence on malignant cells coupled with the fact that only unique GPI 
(glycosylphosphatidylinositol anchored folate receptor is the only form capable of uptake of 
folate conjugated species (reduced folate carrier is incapable of uptake of folate conjugates). This 
characteristic of malignant cells can be useful for the diagnosis of cancer
13-14
. Folate receptors 
can be used for many kinds of folate conjugates like targeted drug delivery for cancer treatment 
and attached conjugate will not release and will not be degraded. Within the endosome, the folate  
imaging agent conjugate is released from the folate receptor. 
 
Folate Conjugates: 
 Folate can be coupled with different molecules including chemotherapeutic agents, protein 
toxins, immunotherapeutic agents, antisense oligonucleotides; liposomes entrapped drug, 
polymeric drug carrier and imaging agents.
15
 Imaging agents can be conjugated to folic acid 
using variety of linkers and cleavable bonds without affecting the binding affinity of the folate 
moiety to the folate receptor. (Figure: 2 shows the schematic representation of folate-dye 
conjugates) Peptides or carbon chain can be used as spacer depending upon the size of imaging 
agent.
16-17 
Folate based conjugates have exceptionally good penetration power due to its low 
molecular weight as compared to antibodies. Production cost of antibodies is very high which 
leads to higher cost for in vivo as well as in vitro diagnosis.
18 
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Folate receptor pathway: 
Folate-conjugates bind folate receptor with high affinity
19-20
 and are subsequently 
engulfed in as endosomes and that can reduce disulfide bonds of the linkers. In the absence of 
any cleavage of the bond, the attached conjugate will not release and will not be degraded. 
Within the endosome, the folate imaging agent conjugate is released from the folate receptor 
(Figure-3). 
 
Dylight
TM
 800 Maleimide: 
The DyLight
TM
 800 belongs to DyLight line of fluorescent dyes which are fabricated 
by Dyomics in collaboration with Thermo Fisher Scientific. DyLight dyes have a broad range of 
application including in biotechnology and research applications as biomolecules, cell and tissue 
labels for fluorescence related studies, cell biology or molecular biology. 
Classical fluorophores such as fluorescein and Rhodamine have been used in a wide 
range of applications. But these dyes have certain limitations for use in microscopy and other 
applications that require exposure to an intense light source and high temperatures  such as a 
laser, because they photo-bleach very quickly. DyLight family of Fluorophors have similar 
excitation and emission spectra and are exceptionally photostable, brighter, and less pH -
sensitive. The excitation and emission spectra of the DyLight Fluorophores series covers the 
visible spectrum and also extends into the near infrared region, allowing detection using most of 
the fluorescence microscopes, as well as special infrared imaging systems. 
 DylightTM 800 products (Table-1). 
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 DylightTM 800 properties and applications (Figure-4). 
Thermo scientific Dylight 800 is near-IR flour that is invisible to the naked eye but increases 
the staining options when using infrared imaging systems. Dylight 800 has spectral properties
21-
24
 which are very similar to other near-IR dyes, including Alexa Fluor*790 and IR*Dye 800, and 
has high solubility for maximal incorporation into the biomolecule of interest.
22-23 
 
Physical properties of Thermo Scientific DyLight
TM
 800 dye:
27-29 
Physical characteristics of Thermo Scientific Dylight
TM
 800 dye, including excitation/emission 
spectra, emitted color, extinction coefficient, the correction factor used to quantitate labeled 
protein, the molecular weight of the dye and comparable commercial dyes.
30
 Right panel: 
Excitation (black) and emission (brown) spectra for Thermo Scientific Dylight 800 dye
25-26 
(Figure-4).  
 
Thermo Scientific Dylight
TM
 800 derivatives for a broad range of applications:
27-28
 
Dylight 800 reactive derivatives for labeling: 
 Amine-reactive dye (N-hydroxysuccinimide (NHS) ester-activated).27-28 
 Sulfhydryl-reactive dye (Maleimide-activated).27-28 
 Free acid dye – non reactive; used as negative control. 27-28 
Dylight 800-conjugated fluorescent probes: 
 Secondary antibody-conjugated- Goat Anti-Mouse or Anti-Rabbit. 27-28 
 Streptavidin-conjugated. 27-28 
 Neutravidin protein-conjugated. 27-28 
Additional fluorescence-based applications:
 27-28
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 In-Cell ELISA Near Infrared Detection Kit. 27-28 
Materials and Instrumentation used for Synthesis: 
 
1. DyLightTM 800 Maleimide is the main product 1mg, stored at -2000C Product#46621, 
Lot#KK12610414 
2. DMSO: Sigma Aldrich, 99% purity; Folate Cysteine: Provided by Dr. Henne ; 
Fluorescein sodium salt(C20H10Na2O5) : Lot# 079K0141V; Multichannel pipetter : 
RAININ , 20-300µl; 
3. UV Plates: BD Falcon microtest 96 well 370µl clear plate, UV Vis transparent film 
bottom, 
4. Non-sterile, no lid, lot No:E1002007; Regular Plates: Generic Bio-One, microplate, 
96well flat bottom, Lot No: E091006L; Spin Filters : Sigma Aldrich, Amicon ultra 0.5 
centrifugal filter, 
5. 3 kDa, Batch No: 3110; PD-10 Columns: Sephadex G-25M columns, contains 0.15% 
Kathon CG in DI H20, lot no. 393861; Centrifuge: Beckman CS-15R Centrifuge at 8898 
RPM for 12 mins. 
6. UV Plate Reader and BCA assay Software: Gen 5.1.10 Biotek, Epoch. 
7. DIPEA (N,N-Diisopropylethylamine) 
8. Synthesized Folate – Peptide (Folate-Asp-Arg-Asp-Asp-Cys-SH supplied by W. Henne), 
DyLight
TM
 800 maleimide was supplied by Thermo Scientific, 99% DIPEA ( N,N-
Dissopropylethylamine) supplied by Aldrich chemicals, DMSO ( Dimethylsulfoxide) 
supplied by fischer swcientific. 
9. HPLC instrumentation and UV-visible spectrophotometer. 
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Method and Analysis: 
 
Synthesis of Folate-DyLight
TM
 800: 
 1 mg DyLight
TM
 800 maleimide was dissolved in 200 ul dimethylsufoxide(DMSO). 2 mg 
of folate peptide cysteine and 10 ul of DIPEA (N,N-Diisopropylethylamine) were added and 
mixed overnight using a magnetic stirrer (at room temperature). The product was purified by 
reverse phase HPLC and analyzed by LC/MS, UV-Vis spectrophotometer. The synthesis of 
Folate-Dylight 800 maleimide is shown in (figure -5). 
 
Preparation of Buffers: 
Take 0.45 g of ammonium bicarbonate and add 500 ml of distilled water and then stir to 
dissolve (10 mM bicarbonate buffer, pH ~ 6.8).   
 
Experimental Parameters for HPLC: 
The analysis of synthesized product was done by HPLC (Hewlett Packard, series1050) 
with YMC, HPLC column with particle size 6µm and dimension 4.6 x 150 mm. Purification was 
done by Rigel HPLC with particle size 5 µm and column dimension 10 x 250 mm. 
Solvents used: ammonium bicarbonate/acetonitrile  
Flow rate is 1 ml/min 
Detector: DAD with scanning range 200-600  
Method used is BIOTINRH.M 
 12 
Gradient method for Folate - Dylight conjugates purification (HPLC) 
 
Time (min) % B 
0.00 1 
1.00 1 
20.0 99 
40.0 99 
41.0 99 
50.0 99 
52.0 1 
60.0 1 
 
Experimental parameters for UV-Visible Spectrophotometer: 
Instrument: Epoch Microplate Spectrophotometer 
U.V Plate Reader Analysis at λ = 777nm of stock containing 1:10 dilution of purified dylight 800 
in PBS was conducted. 
Experimental Parameters for LC/MS: 
Initially sample was centrifuged for 7 mins at 12.2 p/min and supernatant sample was extracted. 
Then 100 μL of folate dylight 800 was injected into LC/MS. 
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Column Parameters 
 
Mode Positive ion mode 
Flow rate 5ml/min 
Solvent A Water 
Solvent B Methanol 
Column XDB-C18 
Scan range 500 – 2200 m/z 
Nebulizer Pressure 40 psi 
Threshold 1000 
Drying gas Temperature 300C 
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Competition Studies of DyLight 
TM
 800 using FTR:  
 
 
 
Results and Discussion: 
The synthesis of Folate –DyLightTM 800 was a very simple and quick method. In this 
method, the folate-peptide and DyLight
TM
 800 was conjugated via maleimide chemistry 
(thioether linkage). The synthesis method was inexpensive and can be performed in small 
laboratories. The main advantage of this synthetic approach is that folate-peptide is very stable 
and can be stored for a long time and can be scaled to 0.5 gram batches.   
Step 1 
• Test (D) : 100 μL of Dylight 800 + RPMI medium in L1210 FR cancer cells 
incubated for 10 mins 
Step 2 
• Control (R) : RPMI medium in L1210 FR cells incubated for 10 mins 
 
Step 3 
• 10 μL FTR medium was added to both D and R and incubated for 35 mins. 
Then both the tubes were centrifuged and washed with 1ml PBS thrice and 
finally 10 μL of PBS was added to both the tubes. 
Step 4 
• Slides were prepared for observation under microscope. 
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The purification of Folate-DyLight
TM
 800 conjugate was accomplished using reversed 
phase HPLC. Total run time was 1 hour (60 mins). For the analytical run, 10 µl injection of the 
product was injected in HPLC and analyzed. Peaks were observed at 11.4 min, 15.9 min, 16.4 
min, 17, 5 min, 18.6 min. From these peaks, the sample from peaks at 17.5 min and 18.6 min 
were collected and stored it in the vials and these purified samples we injected 10 µl each in the 
HPLC for analysis. Also UV-Vis of the collected fractions were assessed using a spectral scan in 
a UV/ViS micro-plate reader. In the HPLC chromatogram, at 17.7 min we observed the 
unreacted folate cysteine peak, the compound Folate-DyLight 800 peak at 21.1 min and the 
unreacted dye peak at 32.3 min (Figure-6). At 18.6 min we have clearly observed few peaks 
with small intensities. It is largely anticipated that the compound at 21.2 min is folate dylight 800 
(Figure-7).  
By using the microplate reader we observed the characteristic DyLight 800 peak at around 790 
nm. We also observed the characteristic folate doublet at 280 and 363 nm. The spectrum is 
displayed in Figure-8. 
From LC/MS chromatogram a distinct peak at 3.252 min was observed corresponding to that of 
Folate -DyLight 800 (Figure-10). Offline session was conducted and the DAD spectrum was 
produced which showed the DyLight – 800 peak at 800 nm and Folate peak at 330 nm (Figure-
9). 
Competition studies with Rhodamine showed that higher concentration of DyLight 800 competes 
and binds with L1210 FR cancer cells (Figure-12). More Dylight 800 prevents FTR from 
binding with folate receptors on the cancer cells. The other slide (control) showed dark red spots 
of FTR binding to cancer cells (Figure-11). 
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Conclusion: 
Folate-Dylight
TM
 800 was successfully synthesized by very simple, inexpensive and safe 
method. The whole synthesis method can be performed in small laboratories with minimum 
resources and small quantity of reagents required. The synthesis of Folate-Dylight
TM
 800 
conjugate was successfully purified by HPLC. The purified Folate-Dylight
TM
 800 conjugate was 
evaluated by LC/MS, UV-Vis and HPLC.  
Competition studies of DyLight
TM
 800 showed that high concentrations of our dye competes 
with FTR and binds to L1210 FR cancer cells. 
 
 
Figures: 
   
 
                                      
Source: Folic Acid - Bristol University homepage - a place for ... (n.d.). Retrieved from 
http://www.chm.bris.ac.uk/webprojects2002/schnepp/folic.html 
 
(Figure: 1) Structure of folic acid 
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(Figure:2) General Scheme for Folate-Dye conjugates 
Source:   ScienceDirect.com - Advanced Drug Delivery Reviews - Optical ... (n.d.). Retrieved 
from http://www.sciencedirect.com/science/article/pii/S0169409X05000566 
                                                                        
 
          Source: Christopher P. Leamon. Drug Receptor pathway. Sciencedirect.com. 17  Nov 2012. 
<http://www.sciencedirect.com/science/article/pii/S135964460001944> 
        
(Figure:3) Transportation of Folate-conjugates via Folate receptors. 
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Source: DyLight Fluor Labeling Reagents and Kits - Protein ... (n.d.). Retrieved from 
http://www.piercenet.com/browse.cfm?fldID=294EFD98-4461-4352-A046-50B522F52952 
 
Table-1 Dylight Products 
Product  Color mass (g/mol) Absorb (nm) Emit (nm) 
ε (M-1cm-
1
) 
DyLight 350 violet 874 353 432 15,000 
DyLight 405 violet 793 400 420 30,000 
DyLight 488 green 1011 493 518 70,000 
DyLight 550 yellow 982 562 576 150,000 
DyLight 594 orange 1078 593 618 80,000 
DyLight 633 red 1066 638 658 170,000 
DyLight 650 red 1008 654 673 250,000 
DyLight 680 far-red 950 692 712 140,000 
DyLight 755 near-IR 1092 754 776 220,000 
DyLight 800 near-IR 1050 777 794 270,000 
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                                                                  Excitation 
                                                                        Emission  
                
 
(Figure-4) Thermo Scientific Dylight
TM
 800  
Properties 
Source: DyLight Fluor Labeling Reagents and Kits - Protein ... (n.d.). Retrieved from 
http://www.piercenet.com/browse.cfm?fldID=294EFD98-4461-4352-A046-50B522F52952 
 
     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thermo Scientific Dylight 800 Properties 
 
Excitation(nm) 777 
Emission(nm) 794 
Color Near-IR 
€† 270,000 
CF‡ 0.045 
Mol.Weight(g/mol) 899.15 
Spectrally similar Dyes Alexa Fluor*790,  
IR Dye*800 
†Molar extinction coefficient (M-1 cm-1) 
‡ Correction factor(A260/A777) 
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                                                                 + 
                                             Dylight
TM
 800 Maleimide 
                        
 
  
Folate Dylight
TM
 800 Maleimide conjugate 
(Figure:5) Schematic Representation of Folate Dylight
TM
 800 Maleimide conjugate 
synthesis 
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(Figure:6) Chromatogram of crude Folate-Dylight
TM 
800 
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(Figure: 7) Chromatogram of purified Folate-Dylight
TM 
800 conjugates at 21.1 min. 
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(Figure: 8) UV-Vis of Folate-Dylight
TM 
800 conjugates 
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          (Figure: 9) DAD spectrum of Folate Dylight
TM 
800 
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  (Figure: 10) LC/MS chromatogram of Folate DyLight 800 Conjugate 
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(Figure: 11) Slide R containing L1210 FR cancer cells in FTR 
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(Figure: 12) Slide D showing a light red spot due to binding of DyLight
TM
 800 with L1210 
FR Cancer cells. 
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